Christopher Gibson - 08 Dec 2021 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: Chief Executive Officer, Director
Signature: /s/ Jonathan Golightly, attorney-in-fact
Issuer symbol: RXRX
Transactions as of: 08 Dec 2021
Net transactions value: -$165,807
Form type: 4
Filing time: 10 Dec 2021, 20:42:15 UTC
Previous filing: 09 Dec 2021
Next filing: 15 Dec 2021
SEC: View on sec.gov

Quoteable Key Fact

"Christopher Gibson filed Form 4 for RECURSION PHARMACEUTICALS, INC. (RXRX) on 10 Dec 2021."

Quick Takeaways

This page summarizes Christopher Gibson's Form 4 filing for RECURSION PHARMACEUTICALS, INC. (RXRX).
9 reported transactions and 6 derivative rows are listed below.
Filing timestamp: 10 Dec 2021, 20:42.

What Changed

Previous filing in this sequence was filed on 09 Dec 2021.
Current net transaction value: -$165,807.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Options Exercise	$70,756	+28,646		$2.47	28,646	08 Dec 2021	Direct	F1
transaction	RXRX	Class A Common Stock	Sale	$103,670	-5,176	-18%	$20.03	23,470	08 Dec 2021	Direct	F1, F2
transaction	RXRX	Class A Common Stock	Conversion of derivative security	$0	+5,488	+23%	$0.000000	28,958	08 Dec 2021	Direct	F1, F3
transaction	RXRX	Class A Common Stock	Sale	$111,162	-5,488	-19%	$20.26	23,470	08 Dec 2021	Direct	F1, F4
transaction	RXRX	Class A Common Stock	Conversion of derivative security	$0	+1,086	+4.6%	$0.000000	24,556	09 Dec 2021	Direct	F1, F3
transaction	RXRX	Class A Common Stock	Sale	$21,730	-1,086	-4.4%	$20.01	23,470	09 Dec 2021	Direct	F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXRX	Stock Option (Right to Buy)	Options Exercise	$0	-28,646	-1.9%	$0.000000	1,471,354	08 Dec 2021	Class A Common Stock	28,646	$2.47	Direct	F1, F6, F7
transaction	RXRX	Class B Common Stock	Conversion of derivative security	$0	-5,488	-0.07%	$0.000000	8,195,728	08 Dec 2021	Class A Common Stock	5,488	$0.000000	Direct	F1, F3, F8, F9
transaction	RXRX	Class B Common Stock	Conversion of derivative security	$0	-1,086	-0.01%	$0.000000	8,194,642	09 Dec 2021	Class A Common Stock	1,086	$0.000000	Direct	F1, F3, F8, F9
holding	RXRX	Class B Common Stock						550,000	08 Dec 2021	Class A Common Stock	550,000	$0.000000	by LAHRAWN-3 LLC	F8, F9, F10
holding	RXRX	Class B Common Stock						550,000	08 Dec 2021	Class A Common Stock	550,000	$0.000000	by LAHRAWN-4 LLC	F8, F9, F11
holding	RXRX	Class B Common Stock						146,875	08 Dec 2021	Class A Common Stock	146,875	$0.000000	by Gibson Family Trust	F8, F9, F12

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2	This transaction, representing a sale to cover the exercise price and related tax withholdings for 28,646 option shares, was executed in multiple trades at prices ranging from $20.014 to $20.21. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3	Represents the conversion of Class B Common Stock into Class A Common Stock.
F4	This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5	This transaction was executed in multiple trades at prices ranging from $20.00 to $20.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6	The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7	This option, originally reported in the Reporting Person's Form 3 as exercisable for Class B Common Stock, is in fact exercisable for Class A Common Stock. Upon exercise of the option, the Reporting Person has the right to require the Issuer to exchange any such shares of Class A Common Stock for a number of Class B Common Stock of equivalent value.
F8	Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F9	Shares of Class B Common Stock held directly and indirectly by the Reporting Person were previously reported in Table I of Forms 4 filed by the Reporting Person. Commencing with this Form 4, shares of Class B Common Stock held directly and indirectly by the Reporting Person are to be reported in Table II of Form 4.
F10	The shares are held by LAHWRAN-3 LLC, of which the Reporting Person a member and a manager.
F11	The shares are held by LAHWRAN-4 LLC, of which the Reporting Person a member and a manager.
F12	The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.